TempraMed Technologies (FRA:9DY) Common Stock: €22.93 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9DY TempraMed Technologies Ltd FRA:9DY
10 GF Score
Price €0.25
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies Common Stock?

TempraMed Technologies FRA:9DY -23.33% 10 Common Stock is €22.93 Mil as of Mar. 2026. GuruFocus rates FRA:9DY with a GF Score™ of 10/100. The stock has 5 warning signs investors should review.

TempraMed Technologies's quarterly common stock increased from Sep. 2025 (€20.24 Mil) to Dec. 2025 (€20.32 Mil) and increased from Dec. 2025 (€20.32 Mil) to Mar. 2026 (€22.93 Mil).

TempraMed Technologies's annual common stock increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.68 Mil) and increased from Dec. 2024 (€0.68 Mil) to Dec. 2025 (€20.32 Mil).

TempraMed Technologies Common Stock Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies Common Stock Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
Common Stock
0.00 0.68 20.32

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only 0.00 23.85 20.24 20.32 22.93
FRA:9DY
10GF Score
TempraMed Technologies Ltd FRA:9DY
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €22.93 Mil mean?
TempraMed Technologies (FRA:9DY) has a Common Stock of €22.93 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on TempraMed Technologies and its competitors.
Is TempraMed Technologies' Common Stock too high?
TempraMed Technologies' current Common Stock is €22.93 Mil. Overall, TempraMed Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Common Stock compare to ABT and SYK?
TempraMed Technologies' Common Stock of €22.93 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current Common Stock is €22.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current Common Stock of €22.93 Mil. The current Common Stock is €22.93 Mil. TempraMed Technologies' overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current Common Stock is €22.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
10GF Score

Get the complete analysis for FRA:9DY

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price